Contact dermatitis guide: allergic vs. irritant, patch testing, and the most common skincare allergens

Contact dermatitis is among the most common dermatologic conditions, affecting up to 20% of the general population at some point. It is also one of the most actionable — because identifying and eliminating the trigger produces definitive resolution, unlike many chronic inflammatory skin diseases that require indefinite management. The key distinction between allergic and irritant contact dermatitis determines the investigation approach and the threshold for reaction. Here is the complete evidence-based guide.

Two distinct mechanisms

Allergic contact dermatitis (ACD): immune-mediated

Allergic contact dermatitis is a Type IV hypersensitivity reaction — a T-cell-mediated delayed immune response.

The two-phase mechanism:

Phase 1 — Sensitization (first exposure):

1. A hapten (small reactive molecule, typically <500 Da) penetrates the skin
2. The hapten binds to skin proteins → forms a hapten-protein conjugate (an antigenic compound)
3. Langerhans cells (dendritic cells in the epidermis) capture the conjugate → migrate to regional lymph nodes → present antigen to naïve T cells
4. Antigen-specific CD4+ and CD8+ T cells are generated and become memory T cells → circulate systemically
5. No clinical reaction during sensitization — the patient is unaware this has occurred

Phase 2 — Elicitation (subsequent exposures):

1. Re-exposure to the same hapten → skin hapten-protein conjugate forms again
2. Memory T cells recognize the antigen → activate → release pro-inflammatory cytokines (IFN-γ, IL-17, TNF-α)
3. Clinical reaction appears 48–96 hours after exposure (the characteristic delayed onset of Type IV hypersensitivity)
4. Reaction: erythema, vesiculation, pruritus, scaling — at the site of contact

Key features:

• Can occur after years of using the same product — sensitization can develop after repeated exposures
• No concentration threshold — even minute amounts of the allergen trigger the full elicitation reaction in sensitized individuals
• Reaction spreads beyond the contact site (the immune reaction is systemic once sensitized, so distant skin can react)
• Resolves with allergen avoidance; recurs on re-exposure

Irritant contact dermatitis (ICD): non-immune

ICD is not immune-mediated — it is a direct dose-dependent cytotoxic effect of the irritant on skin cells.

Mechanism:

1. Irritant directly damages keratinocytes → releases IL-1α, IL-1β, TNF-α from damaged cells → inflammatory response
2. No sensitization phase required — anyone will react to a sufficient concentration of a sufficient irritant
3. Reaction is proportional to dose, duration, and concentration of exposure

Key features:

• Concentration-dependent: There is a threshold — below a certain concentration/duration of exposure, no reaction; above it, reaction
• No prior sensitization required — first exposure can cause reaction
• Does not spread beyond contact area
• More common than ACD overall; accounts for approximately 80% of contact dermatitis cases
• Common causes: sodium lauryl sulfate (SLS), prolonged water exposure (wet work), detergents, solvents, acids, alkalis

Clinical distinction

Feature	Allergic CD	Irritant CD
Onset after exposure	48–96 hours (delayed)	Minutes to hours (or immediate with strong irritants)
Threshold	None — any amount triggers	Dose-dependent
First exposure reaction	No (sensitization required)	Possible (with sufficient irritant)
Spread beyond contact site	Yes (systemic immune response)	No
Diagnosis	Patch test gold standard	Clinical; negative patch test
Mechanism	T-cell Type IV hypersensitivity	Direct cytotoxicity

---

Patch testing: the gold standard for ACD diagnosis

What patch testing is

Patch testing applies diluted concentrations of known allergens to the skin (typically the upper back) under occlusive chambers for 48 hours — then reads the reactions at 48 hours and 96 hours (sometimes also at 7 days for late reactions).

How to interpret:

• Negative: No reaction — patient is not sensitized to that allergen
• +/- (doubtful): Faint, macular erythema only — non-specific
• + (weak positive): Erythema, infiltration, and possible papules — sensitization confirmed
• ++ (strong positive): Erythema, infiltration, papules, vesicles
• +++ (extreme positive): Bullae, coalescing vesicles
• IR (irritant reaction): Distinguished by morphology — typically pustules or follicular pattern at high concentrations; no spreading; fades quickly

Standard series: The European Baseline Series (EBS) and the North American Contact Dermatitis Group (NACDG) baseline series test approximately 30–80 of the most common contact allergens. Supplementary series (fragrance, cosmetic, rubber, metal, etc.) are added based on patient history.

---

The most common skincare and cosmetic allergens

Fragrance

The single most common category of contact allergen in cosmetics. Fragrances are complex mixtures of hundreds of chemical compounds; individual sensitizing components include:

Fragrance Mix I (FM I): A screening mixture of 8 fragrance chemicals (cinnamal, cinnamyl alcohol, geraniol, eugenol, isoeugenol, hydroxycitronellal, amyl cinnamal, evernia prunastri). Positive reaction identifies fragrance allergy in approximately 70–80% of fragrance-allergic patients.

Fragrance Mix II (FM II): A second screening mixture covering additional fragrance chemicals including hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC/Lyral) — a potent allergen banned in the EU since 2019.

Balsam of Peru (Myroxylon pereirae): A natural fragrance ingredient used as a fragrance marker; broad cross-reactivity with many natural fragrances.

"Fragrance-free" vs. "unscented": "Unscented" products may contain masking fragrances; "fragrance-free" means no added fragrance compounds — the safer claim for fragrance-allergic patients.

Preservatives

Methylisothiazolinone (MI) and methylchloroisothiazolinone/methylisothiazolinone (MCI/MI, Kathon CG): The most common preservative allergens in rinse-off and leave-on products. MI sensitization rates increased dramatically after industry shifted to MI-containing preservatives in the 2000s; now among the most prevalent contact allergens in many countries.

Formaldehyde and formaldehyde releasers: Quaternium-15, DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea — preservatives that slowly release formaldehyde as an antimicrobial. Formaldehyde is a potent sensitizer; these releasers produce equivalent sensitization.

Parabens: Historically implicated; in fact, a relatively uncommon contact allergen in clinical patch testing series. The "paraben-free" marketing trend was not primarily driven by clinical sensitization rates but by unrelated safety concerns.

Phenoxyethanol: Increasingly used as a preservative alternative; low sensitization rate; generally better tolerated than isothiazolinones.

Surfactants

Cocamidopropyl betaine (CAPB): A common amphoteric surfactant in "gentle" and "sulfate-free" shampoos and cleansers; a significant sensitizer — reactions to "gentle" cleansers are often due to CAPB rather than SLS (which is an irritant, not a sensitizer). CAPB is one of the top-ranked cosmetic allergens in multiple series.

Sodium lauryl sulfate (SLS): Primarily an irritant, not a sensitizer — important distinction. SLS does not cause allergic sensitization in most individuals but causes dose-dependent irritant reactions.

Other common allergens

Nickel sulfate: The most common metal allergen — from jewelry, belt buckles, watch straps, phone cases. Relevant for facial contact dermatitis from phone cases.

Propylene glycol: A humectant and solvent used widely in skincare; an irritant and occasional sensitizer at high concentrations.

Lanolin (wool alcohols): Historically a significant allergen; modern highly purified lanolin has lower sensitization rates but remains relevant.

Sunscreen ingredients: Para-aminobenzoic acid (PABA — now rarely used), benzophenone-3 (oxybenzone), cinnamates — occasional sensitizers in chemical sunscreens.

---

Identifying the trigger: the systematic approach

The history

1. When did the dermatitis start? What was new or changed in the routine at that time?
2. Where is the reaction? The distribution often identifies the source:
   • Eyelids: Nail polish allergen transferred by touching; eye cream; eyeliner/mascara
   • Perioral: Toothpaste, lip products, mouthwash
   • Neck/décolletage: Fragrance (perfume application sites)
   • Scalp margin/forehead: Shampoo, conditioner, hair dye (PPD — p-phenylenediamine)
   • Hands: Gloves (rubber accelerators), hand cream, cleaning products
3. Does it improve on weekends or holidays? (Occupational exposures)

Elimination testing

Before formal patch testing, systematic elimination of products can identify the category:

• Stop all leave-on products for 2–3 weeks; restart one at a time every 2 weeks
• Switch to a minimal, known-hypoallergenic routine during elimination

Formal patch testing

Refer to a dermatologist with patch testing expertise. Results must be interpreted in the context of the clinical history — a positive patch test to an ingredient you've never used is not clinically relevant; a positive test to an ingredient in your daily routine confirms the diagnosis.

---

Treatment

Acute management

Topical corticosteroids: First-line for acute flares — medium-to-high potency on body, low-potency on face and eyelids. Not a cure — they suppress the inflammation while the allergen is still present.

Topical calcineurin inhibitors: For facial ACD or where long-term anti-inflammatory is needed without steroid atrophy risk.

Oral antihistamines: Limited efficacy for the Type IV hypersensitivity itch (antihistamines work well for Type I/IgE-mediated hives but less so for T-cell-mediated reactions). Sedating antihistamines (diphenhydramine) may help with sleep.

Oral corticosteroids: For severe, widespread ACD (e.g., poison ivy/oak contact dermatitis affecting large body surface area) — a short tapering course over 2–3 weeks.

Definitive treatment: avoidance

The only cure for ACD is identifying and permanently eliminating exposure to the specific allergen. Once sensitization is established, it is lifelong — there is no desensitization protocol equivalent to those available for Type I allergies. Even minute amounts of the allergen will trigger the reaction indefinitely.

Product database tools: CAMP (Contact Allergen Management Program) from the American Contact Dermatitis Society allows patients to input their allergens and receive a database of safe products; SkinSafe is a similar tool.

---

Looking for a skincare or dermatology consultation? Browse med spa providers on MedSpot →